Ultragenyx Pharmaceutical Inc. (RARE) Stock Overview
NASDAQ · Healthcare · Biotechnology
✓ Sourced directly from Yahoo Finance · Checked for accuracy at every rebuild · Snapshot: 6 September 2026
About Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Latin America, Europe, the Middle East, Africa, and the…
Source: Yahoo Finance
Sector & Industry
Ultragenyx Pharmaceutical Inc. operates in the Healthcare sector, within the Biotechnology industry group. It is listed on the NASDAQ exchange.
Ultragenyx Pharmaceutical Inc. at a Glance
| Company | Ultragenyx Pharmaceutical Inc. |
| Ticker | RARE |
| Exchange | NASDAQ |
| Currency | USD |
| Price | $15.30 |
| Market cap | $1.51B |
| P/E ratio (trailing) | — |
| EPS (trailing) | -$5.83 |
| 52-week high | $39.89 |
| 52-week low | $13.81 |
| Dividend yield | — |
| Ex-dividend date | — |
| Beta | 0.32 |
| Return on equity (ROE) | — |
| Debt-to-equity | — |
| Average volume | 3.00M |
| Shares outstanding | 98.59M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 1,371 |
| Country | United States |
Investing Essentials
As an Amazon Associate we earn from qualifying purchases. Links below are affiliate links.
Peter Lynch on how everyday investors can spot winners before the professionals do.
Check Price →Benjamin Graham's classic on value investing — the book Warren Buffett calls the best ever written on the subject.
Check Price →Evaluating pharma pipelines, devices and healthcare economics.
Check Price →Frequently Asked Questions
- What is Ultragenyx Pharmaceutical Inc.'s current P/E ratio?
- Ultragenyx Pharmaceutical Inc. (RARE) has a trailing P/E ratio of — as of our 6 September 2026 data snapshot. Learn what the P/E ratio means →
- What is Ultragenyx Pharmaceutical Inc.'s market capitalisation?
- Ultragenyx Pharmaceutical Inc.'s market cap is $1.51B based on our latest snapshot. See how it ranks by market cap →
- What is RARE's 52-week range?
- Over the past 52 weeks, RARE has traded between $13.81 and $39.89. What does the 52-week range mean? →
- How volatile is Ultragenyx Pharmaceutical Inc. compared to the market?
- Ultragenyx Pharmaceutical Inc. has a beta of 0.32, meaning it has historically moved less than the broader market. What does beta measure? →
- Does Ultragenyx Pharmaceutical Inc. pay a dividend?
- Ultragenyx Pharmaceutical Inc. does not currently pay a dividend according to our latest data.
- What exchange is RARE listed on?
- RARE is listed on the NASDAQ. Browse all NASDAQ-listed stocks →
- What sector is Ultragenyx Pharmaceutical Inc. in?
- Ultragenyx Pharmaceutical Inc. is classified in the Healthcare sector. Compare with Healthcare peers →
For compound interest, percentage change and other investing maths, try our free online calculators.
Many readers keep a stock investing journal to log positions and theses alongside pages like this one, and a dedicated financial calculator to hand for quick valuation maths.
Recommended Reading & Tools
Philip Fisher on what makes a business worth owning for the long term.
Check Price →Burton Malkiel's evidence-based guide to markets, indexing and long-term strategy.
Check Price →Morgan Housel's short lessons on behaviour, luck and long-term wealth.
Check Price →